BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18178624)

  • 1. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.
    Swann JB; Vesely MD; Silva A; Sharkey J; Akira S; Schreiber RD; Smyth MJ
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):652-6. PubMed ID: 18178624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis.
    Rothe M; Quarcoo D; Chashchina AA; Bozrova SV; Qin Z; Nedospasov SA; Blankenstein T; Kammertoens T; Drutskaya MS
    Cancer Med; 2013 Dec; 2(6):815-25. PubMed ID: 24403255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.
    Sharma SD; Meeran SM; Katiyar N; Tisdale GB; Yusuf N; Xu H; Elmets CA; Katiyar SK
    Carcinogenesis; 2009 Nov; 30(11):1970-7. PubMed ID: 19759192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLK6 protease accelerates skin tumor formation and progression.
    Khoury N; Zingkou E; Pampalakis G; Sofopoulos M; Zoumpourlis V; Sotiropoulou G
    Carcinogenesis; 2018 Dec; 39(12):1529-1536. PubMed ID: 30137206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice.
    Rastogi S; Shukla Y; Paul BN; Chowdhuri DK; Khanna SK; Das M
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):228-40. PubMed ID: 17669454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
    Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
    Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-Hydroxypterostilbene Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Mouse Skin Carcinogenesis.
    Lee PS; Chiou YS; Chou PY; Nagabhushanam K; Ho CT; Pan MH
    Phytomedicine; 2021 Jan; 81():153432. PubMed ID: 33310310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.
    Winkler AE; Brotman JJ; Pittman ME; Judd NP; Lewis JS; Schreiber RD; Uppaluri R
    Cancer Res; 2011 Sep; 71(17):5707-16. PubMed ID: 21734014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemene inhibits 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin tumorigenesis through suppression of NF-κB-associated signaling events in the mouse skin model.
    Hu X; Wang L; Zhang L; Zhang T
    J Biochem Mol Toxicol; 2020 Oct; 34(10):e22550. PubMed ID: 32662567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition.
    Lee YS; Lee CH; Bae JT; Nam KT; Moon DB; Hwang OK; Choi JS; Kim TH; Jun HO; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
    J Exp Clin Cancer Res; 2018 Nov; 37(1):293. PubMed ID: 30486830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis.
    Cataisson C; Salcedo R; Hakim S; Moffitt BA; Wright L; Yi M; Stephens R; Dai RM; Lyakh L; Schenten D; Yuspa HS; Trinchieri G
    J Exp Med; 2012 Aug; 209(9):1689-702. PubMed ID: 22908325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
    Kong YH; Xu SP
    Oncol Rep; 2018 Jun; 39(6):2513-2526. PubMed ID: 29693192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
    Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted.
    Yamakage K; Omori Y; Zaidan-Dagli ML; Cros MP; Yamasaki H
    J Invest Dermatol; 2000 Feb; 114(2):289-94. PubMed ID: 10651988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
    Murphy JE; Morales RE; Scott J; Kupper TS
    J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damage.
    Dao V; Pandeswara S; Liu Y; Hurez V; Dodds S; Callaway D; Liu A; Hasty P; Sharp ZD; Curiel TJ
    Cancer Prev Res (Phila); 2015 May; 8(5):400-9. PubMed ID: 25736275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.